NACI rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada.: HP5-137/2022E-PDF ; HP5-137/1-2022E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.911967&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | NACI rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada. |
| Variant title | Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada National Advisory Committee on Immunization rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document |
|
| Note(s) | Issued also in French under title: Réponse rapide du CCNI - orientations provisoires sur l'utilisation d'Imvamuneᴹᴰ dans le contexte des éclosions de variole simienne au Canada. Cover title. At head of title: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220181." "Pub.: 220197." Issued also in HTML format. Includes bibliographical references (pages 22-25). |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, June 2022. ©2022 |
| Description | 1 online resource (25 pages) + summary (5 pages) |
| ISBN | 9780660439082 9780660439990 |
| Catalogue number |
|
| Departmental catalogue number | 220181 220197 |
| Subject terms | Human monkeypox -- Vaccination -- Canada. Human monkeypox -- Vaccination -- Government policy -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: